Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

尿激酶受体和纤连蛋白调节 ERK(MAPK) 与 p38(MAPK) 的活性比率，从而决定体内癌细胞的增殖或休眠